Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas T Ross

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Experimental Medicine|January 28, 2009
Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune functionChristopher J Haines, Thierry D Giffon, Li-Sheng Lu, et al.
BMC Clinical Pathology|December 15, 2015
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patientsXi Wang, Brian Z Ring, Robert S Seitz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 11, 2005
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphomaMegan L Troxell, Erich J Schwartz, Matt van de Rijn, et al.
The British Journal of Ophthalmology|October 11, 2015
EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover studyMichael S Berlin, Cheryl Rowe-Rendleman, Ike Ahmed, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortTyler J Nielsen, Matthew G Varga, Catherine T Cronister, et al.
Plos One|February 6, 2014
Global gene expression analysis reveals a link between NDRG1 and vesicle transportHanne A Askautrud, Elisabet Gjernes, Gjermund Gunnes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2009
A novel five-antibody immunohistochemical test for subclassification of lung carcinomaBrian Z Ring, Robert S Seitz, Rodney A Beck, et al.
Journal of Cutaneous Pathology|November 5, 2011
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsivenessWonwoo Shon, Sarah M Jenkins, Douglas T Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trialsDouglas T Ross, Chung-Yeul Kim, Gong Tang, et al.
Journal of Translational Medicine|August 16, 2022
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patientsRobert S Seitz, Michael E Hurwitz, Tyler J Nielsen, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Experimental Medicine|January 28, 2009
Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune functionChristopher J Haines, Thierry D Giffon, Li-Sheng Lu, et al.
BMC Clinical Pathology|December 15, 2015
Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patientsXi Wang, Brian Z Ring, Robert S Seitz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|November 11, 2005
Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphomaMegan L Troxell, Erich J Schwartz, Matt van de Rijn, et al.
The British Journal of Ophthalmology|October 11, 2015
EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover studyMichael S Berlin, Cheryl Rowe-Rendleman, Ike Ahmed, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohortTyler J Nielsen, Matthew G Varga, Catherine T Cronister, et al.
Plos One|February 6, 2014
Global gene expression analysis reveals a link between NDRG1 and vesicle transportHanne A Askautrud, Elisabet Gjernes, Gjermund Gunnes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2009
A novel five-antibody immunohistochemical test for subclassification of lung carcinomaBrian Z Ring, Robert S Seitz, Rodney A Beck, et al.
Journal of Cutaneous Pathology|November 5, 2011
Angiosarcoma: a study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsivenessWonwoo Shon, Sarah M Jenkins, Douglas T Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trialsDouglas T Ross, Chung-Yeul Kim, Gong Tang, et al.
Journal of Translational Medicine|August 16, 2022
Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patientsRobert S Seitz, Michael E Hurwitz, Tyler J Nielsen, et al.
Pageof 4